Literature DB >> 20200155

Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.

Ke-Jun Han1, Yan Yang, Liang-Guo Xu, Hong-Bing Shu.   

Abstract

Recognition of viral RNA by Toll-like receptor 3 (TLR3) triggers activation of the transcription factors NF-kappaB and IRF3 and induction of type I interferons. TRIF is a Toll-interleukin 1 receptor (TIR) domain-containing adapter protein critically involved in TLR3-mediated signaling. It has been shown that TRIF interacts with TLR3 through their respective TIR domains. In this study, we identified a splice variant of TRIF lacking the TIR domain, which is designated as TRIS. Overexpression of TRIS activates NF-kappaB, interferon-stimulated response element (ISRE), and the interferon-beta promoter, whereas knockdown of TRIS inhibited TLR3-mediated signaling, suggesting that TRIS is involved in TLR3-mediated signaling. Furthermore, we identified an N-terminal TBK1-binding motif of TRIS or TRIF that was important for its interaction with TBK1 and ability to activate ISRE. Activation of ISRE by TRIS also needs its dimerization or oligomerization mediated by its C-terminal RIP homotypic interaction motif. Finally, we demonstrated that TRIS was associated with TRIF upon TLR3 activation by poly(I-C). These findings reveal an unexpected mechanism of TLR3-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200155      PMCID: PMC2857105          DOI: 10.1074/jbc.M109.072231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Structures of the toll-like receptor family and its ligand complexes.

Authors:  Mi Sun Jin; Jie-Oh Lee
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

2.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

3.  NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.

Authors:  J L Pomerantz; D Baltimore
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

4.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

5.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Authors:  Hiroyuki Oshiumi; Misako Matsumoto; Kenji Funami; Takashi Akazawa; Tsukasa Seya
Journal:  Nat Immunol       Date:  2003-01-21       Impact factor: 25.606

6.  Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling.

Authors:  Fumitaka Fujita; Yuko Taniguchi; Takashi Kato; Yasuko Narita; Akiko Furuya; Tatsuhiro Ogawa; Hiroaki Sakurai; Takashi Joh; Makoto Itoh; Mireille Delhase; Michael Karin; Makoto Nakanishi
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

7.  Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.

Authors:  Masahiro Yamamoto; Shintaro Sato; Hiroaki Hemmi; Katsuaki Hoshino; Tsuneyasu Kaisho; Hideki Sanjo; Osamu Takeuchi; Masanaka Sugiyama; Masaru Okabe; Kiyoshi Takeda; Shizuo Akira
Journal:  Science       Date:  2003-07-10       Impact factor: 47.728

8.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

9.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

10.  Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.

Authors:  Shintaro Sato; Masanaka Sugiyama; Masahiro Yamamoto; Yasuyuki Watanabe; Taro Kawai; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

View more
  17 in total

1.  LSm14A is a processing body-associated sensor of viral nucleic acids that initiates cellular antiviral response in the early phase of viral infection.

Authors:  Ying Li; Rui Chen; Qian Zhou; Zhisheng Xu; Chao Li; Shuai Wang; Aiping Mao; Xiaodong Zhang; Weiwu He; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-28       Impact factor: 11.205

2.  STING Requires the Adaptor TRIF to Trigger Innate Immune Responses to Microbial Infection.

Authors:  Xin Wang; Tanmay Majumdar; Patricia Kessler; Evgeny Ozhegov; Ying Zhang; Saurabh Chattopadhyay; Sailen Barik; Ganes C Sen
Journal:  Cell Host Microbe       Date:  2016-09-14       Impact factor: 21.023

Review 3.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

Review 4.  Post-transcriptional regulation of gene expression in innate immunity.

Authors:  Susan Carpenter; Emiliano P Ricci; Blandine C Mercier; Melissa J Moore; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

5.  WDFY1 mediates TLR3/4 signaling by recruiting TRIF.

Authors:  Yun-Hong Hu; Yu Zhang; Li-Qun Jiang; Shuai Wang; Cao-Qi Lei; Ming-Shun Sun; Hong-Bing Shu; Yu Liu
Journal:  EMBO Rep       Date:  2015-03-03       Impact factor: 8.807

6.  A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice.

Authors:  Teri L Kissner; Lionel Moisan; Enrique Mann; Shahabuddin Alam; Gordon Ruthel; Robert G Ulrich; Mitra Rebek; Julius Rebek; Kamal U Saikh
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

7.  Ubiquitin-specific protease 9x deubiquitinates and stabilizes the spinal muscular atrophy protein-survival motor neuron.

Authors:  Ke-Jun Han; Daniel G Foster; Nan-Yan Zhang; Kavdia Kanisha; Monika Dzieciatkowska; Robert A Sclafani; Kirk C Hansen; Junmin Peng; Chang-Wei Liu
Journal:  J Biol Chem       Date:  2012-10-30       Impact factor: 5.157

8.  Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells.

Authors:  Silvia Alboni; Claudia Montanari; Cristina Benatti; Manuel Sanchez-Alavez; Giovanna Rigillo; Joan M C Blom; Nicoletta Brunello; Bruno Conti; M Carmine Pariante; Fabio Tascedda
Journal:  Brain Behav Immun       Date:  2014-03-04       Impact factor: 7.217

Review 9.  The effects of TLR activation on T-cell development and differentiation.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Ying-Xiang Yang; Anthony E T Yeo
Journal:  Clin Dev Immunol       Date:  2012-06-07

10.  An alanine-to-proline mutation in the BB-loop of TLR3 Toll/IL-1R domain switches signalling adaptor specificity from TRIF to MyD88.

Authors:  Brett Verstak; Christopher J Arnot; Nicholas J Gay
Journal:  J Immunol       Date:  2013-11-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.